research reports and media, page-2313

He's a vet that has seen "amazing" outcomes for the various species of animals he has directly treated. He has a novel and non-technical way of explaining PPS's MOA which I thought was constructive.

His comments on human trials seems less well informed and can only relate to long term oral application. If you look at Elmiron's labelling it does make some observations on potential AE but certainly not to warrant "uncontrollable bleeding". The link I provided also highlights that exces alarm is not warranted.

I note some vets will not commence surgery if PPS is still the animals system given it acts as a mild blood thinner. This MOA itself allows for improved circulation within the joint and therefore eventual repair.

I'd also note (again as an expert in nothing in particular) that most surgical procedures typically require us (humans) to abstain from taking other prescribed medication to avoid complications such as excess bleeding.